<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04845711</url>
  </required_header>
  <id_info>
    <org_study_id>34503/2/21</org_study_id>
    <nct_id>NCT04845711</nct_id>
  </id_info>
  <brief_title>Ultrasound Guided Erector Spinae Plane Block Versus Quadratus Lumborum Block in Laparoscopic Cholecystectomy</brief_title>
  <official_title>Ultrasound Guided Erector Spinae Plane Block Versus Quadratus Lumborum Block for Postoperative Analgesia in Laparoscopic Cholecystectomy Surgeries: A Randomized Controlled Trial</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Tanta University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Tanta University</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The aim of this study is to compare between the efficacy of ultrasound guided erector spinae&#xD;
      plane block and ultrasound guided quadratus lumborum block in managing acute postoperative&#xD;
      pain in patients undergoing laparoscopic cholecystectomy.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">May 1, 2021</start_date>
  <completion_date type="Anticipated">November 1, 2021</completion_date>
  <primary_completion_date type="Anticipated">October 31, 2021</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Double (Participant, Outcomes Assessor)</masking>
    <masking_description>Patients and medical personnel collecting data and conducting follow-up will be blinded to the group of the patient. All blocks will be performed by one anesthesiologist who will not participate in data collection or analysis.</masking_description>
  </study_design_info>
  <primary_outcome>
    <measure>The degree of postoperative pain in the first 24 hours post-operative</measure>
    <time_frame>first 24 hours post-operative</time_frame>
    <description>Postoperative pain will be assessed by the numerical rating scale (NRS); 0 no pain while 10 is the maximum pain) after discharge to the ward ,and at 6, 12, 18, 24 hours.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Time to first analgesic requirement</measure>
    <time_frame>first 24 hours post-operative</time_frame>
    <description>Intravenous morphine 2 mg will be given when the numerical rating scale (NRS) equal or above 4</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Total dose of intraoperative consumption of fentanyl</measure>
    <time_frame>intraoperative</time_frame>
    <description>Fentanyl 0.5 Î¼g/kg will be given if there was increase in heart rate or mean arterial blood pressure more than 20% (after exclusion of other causes than pain).</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Total dose of rescue analgesia in the first 24hr postoperative</measure>
    <time_frame>first 24 hours post-operative</time_frame>
    <description>Total morphine consumption 24 hours after surgery will be recorded. Intravenous morphine 2 mg will be given when the numerical rating scale (NRS) equal or above 4</description>
  </secondary_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Anticipated">60</enrollment>
  <condition>Laparoscopic Cholecystectomy</condition>
  <condition>Postoperative Analgesia</condition>
  <condition>Erector Spinae Plane Block</condition>
  <condition>Quadratus Lumborum Block</condition>
  <arm_group>
    <arm_group_label>Control group</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>patients will receive general anesthesia only.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Erector spinae plane block group</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>patients will receive general anesthesia and bilateral ultrasound guided erector spinae plane block (20ml Bupivacaine 0.25%)</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Quadratus lumborum block group</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>patients will receive general anesthesia and bilateral ultrasound guided quadratus lumborum block (20 ml Bupivacaine 0.25%)</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Control group</intervention_name>
    <description>patients will receive general anesthesia only.</description>
    <arm_group_label>Control group</arm_group_label>
    <other_name>Group C</other_name>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Erector spinae plane block group</intervention_name>
    <description>patients will receive general anesthesia and bilateral ultrasound guided erector spinae plane block (20ml Bupivacaine 0.25%)</description>
    <arm_group_label>Erector spinae plane block group</arm_group_label>
    <other_name>group ESPB</other_name>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Quadratus lumborum block group</intervention_name>
    <description>patients will receive general anesthesia and bilateral ultrasound guided quadratus lumborum block (20 ml Bupivacaine 0.25%)</description>
    <arm_group_label>Quadratus lumborum block group</arm_group_label>
    <other_name>group QLB</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  aged 21-65 years&#xD;
&#xD;
          -  both genders&#xD;
&#xD;
          -  American Society of Anesthesiology (ASA) class I-II&#xD;
&#xD;
          -  Undergoing elective laparoscopic cholecystectomy&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Patient refusal.&#xD;
&#xD;
          -  Coagulopathy.&#xD;
&#xD;
          -  History of allergy to local anaesthetic.&#xD;
&#xD;
          -  History of liver or renal pathology affecting drug elimination&#xD;
&#xD;
          -  Mental dysfunction or cognitive disorders.&#xD;
&#xD;
          -  Use of medication such as gabapentin-pregabalin that could affect pain perception.&#xD;
&#xD;
          -  Body Mass Index &gt; 40 kg/m2.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>21 Years</minimum_age>
    <maximum_age>65 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Mai E Hamada, MBBCH</last_name>
    <role>Principal Investigator</role>
    <affiliation>Resident of Anesthesiology, Surgical Intensive Care and Pain Medicine</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Mai E Hamada, MBBCH</last_name>
    <phone>00201285851295</phone>
    <email>mai154450_pg@med.tanta.edu.eg</email>
  </overall_contact>
  <verification_date>April 2021</verification_date>
  <study_first_submitted>April 11, 2021</study_first_submitted>
  <study_first_submitted_qc>April 11, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">April 15, 2021</study_first_posted>
  <last_update_submitted>April 11, 2021</last_update_submitted>
  <last_update_submitted_qc>April 11, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">April 15, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Tanta University</investigator_affiliation>
    <investigator_full_name>Mai Elsaid Hamada</investigator_full_name>
    <investigator_title>Resident of Anesthesiology, Surgical Intensive Care and Pain Medicine</investigator_title>
  </responsible_party>
  <patient_data>
    <sharing_ipd>Yes</sharing_ipd>
    <ipd_description>Data are available upon reasonable request from the principal investigator</ipd_description>
    <ipd_info_type>Study Protocol</ipd_info_type>
    <ipd_info_type>Statistical Analysis Plan (SAP)</ipd_info_type>
    <ipd_time_frame>6 months after the end of study For 2 years</ipd_time_frame>
    <ipd_access_criteria>Data are available upon reasonable request from the principal investigator</ipd_access_criteria>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

